GeneDx Holdings (WGS) Debt to Equity: 2020-2025
Historic Debt to Equity for GeneDx Holdings (WGS) over the last 5 years, with Sep 2025 value amounting to $0.18.
- GeneDx Holdings' Debt to Equity fell 30.64% to $0.18 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.18, marking a year-over-year decrease of 30.64%. This contributed to the annual value of $0.21 for FY2024, which is 8.39% down from last year.
- Latest data reveals that GeneDx Holdings reported Debt to Equity of $0.18 as of Q3 2025, which was down 5.37% from $0.19 recorded in Q2 2025.
- In the past 5 years, GeneDx Holdings' Debt to Equity ranged from a high of $0.27 in Q2 2024 and a low of -$0.04 during Q1 2021.
- Over the past 3 years, GeneDx Holdings' median Debt to Equity value was $0.20 (recorded in 2025), while the average stood at $0.17.
- Its Debt to Equity has fluctuated over the past 5 years, first spiked by 1,173.55% in 2024, then slumped by 30.64% in 2025.
- Quarterly analysis of 5 years shows GeneDx Holdings' Debt to Equity stood at $0.04 in 2021, then climbed by 10.53% to $0.04 in 2022, then soared by 495.59% to $0.23 in 2023, then dropped by 8.39% to $0.21 in 2024, then slumped by 30.64% to $0.18 in 2025.
- Its Debt to Equity stands at $0.18 for Q3 2025, versus $0.19 for Q2 2025 and $0.20 for Q1 2025.